The Goldman Sachs Group, Inc. 13D and 13G filings for Addex Therapeutics Ltd:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-07 6:08 pm Sale | 2022-12-30 | 13G | Addex Therapeutics Ltd ADXN | GOLDMAN SACHS GROUP INC GS | 103 0.000% | -150,246 (-99.93%) | Filing |
| 2022-02-14 3:32 pm Purchase | 2021-12-31 | 13G | Addex Therapeutics Ltd ADXN | GOLDMAN SACHS GROUP INC GS | 150,349 6.100% | 150,349 (New Position) | Filing |